CureVac gains COO and hands Florian von der Mülbe new assignment in the midst of Covid-19 vaccine troubles; As Ken Frazier retires, Merck hires chief strategy officer
→ Aiming to bounce back and trying to accentuate the positive after its mRNA Covid-19 vaccine took a major pratfall, CureVac is shaking things up by bringing in Malte Greune as COO and giving new responsibilities to co-founder and chief production officer Florian von der Mülbe. Greune jumps on board from Sanofi after a nearly 10-year run where he was stationed in Germany and spent the last several months as general manager and VP, cartridges, devices & insulin technology group in Frankfurt.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.